We are live on
!
Find out more
TWM
Thrive Wealth Management Portfolio holdings
AUM
$787M
1-Year Est. Return
23.6%
This Fund
S&P 500
This Quarter
Est. Return
+9.52%
1 Year Est. Return
+23.6%
3 Year Est. Return
+73.76%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$619M
AUM Growth
+$96.1M
(+18%)
Cap. Flow
+$48.6M
Cap. Flow
% of AUM
7.84%
Top 10 Holdings %
Top 10 Hldgs %
62.27%
Holding
237
New
18
Increased
118
Reduced
83
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$11M |
| 2 |
Schwab US Large-Cap Growth ETF
SCHG
|
+$7.65M |
| 3 |
iShares National Muni Bond ETF
MUB
|
+$7.61M |
| 4 |
Vanguard Value ETF
VTV
|
+$3.95M |
| 5 |
Loar Holdings
LOAR
|
+$3.54M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$847K |
| 2 |
iShares International Equity Factor ETF
INTF
|
+$804K |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$310K |
| 4 |
Chemed
CHE
|
+$248K |
| 5 |
Elevance Health
ELV
|
+$214K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.64% |
| 2 | Financials | 4.17% |
| 3 | Healthcare | 3.03% |
| 4 | Communication Services | 2.44% |
| 5 | Industrials | 2.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Editas Medicine
EDIT
$457M
| $73.7K | 0.01% |
33,500
| – | – |
|
227
Caribou Biosciences
CRBU
$164M
| $40.3K | 0.01% |
32,000
| – | – |
|
228
ImmunityBio
IBRX
$8.04B
| $39.7K | 0.01% |
15,041
+4,964
| +49% | +$13.3K |
|
229
OmniAb
OABI
$307M
| $30.1K | ﹤0.01% |
17,281
+1,200
| +7% | +$2.01K |
|
230
Aflac
AFL
$63.5B
| – | – |
-1,836
| Closed | -$204K |
|
|
231
Chemed
CHE
$6.77B
| – | – |
-403
| Closed | -$248K |
|
|
232
Elevance Health
ELV
$80.9B
| – | – |
-492
| Closed | -$214K |
|
233
Exelon
EXC
$47.3B
| – | – |
-4,541
| Closed | -$209K |
|
234
Rivian
RIVN
$25.3B
| – | – |
-10,965
| Closed | -$137K |
|
|
TERN
235
DELISTED
Terns Pharmaceuticals
TERN
| – | – |
-10,500
| Closed | -$29K |
|
236
State Street Financial Select Sector SPDR ETF
XLF
$54.8B
| – | – |
-4,151
| Closed | -$207K |
|
|
237
State Street Technology Select Sector SPDR ETF
XLK
$114B
| – | – |
-3,004
| Closed | -$310K |
|
Similar funds
FAMI
GCM
RBC
SBCM
SWIG
NEAM
JSL
LSPW
Thrive Wealth Management's Q2 2025 Portfolio in Review
As of Q2 2025, Thrive Wealth Management held 237 positions worth $619M, up 18% from $523M the previous quarter. Its ten largest holdings account for 62% of the portfolio.
Thrive Wealth Management deployed $48.6M of net new capital in Q2 2025, opening 18 new positions and adding to 118 existing holdings. Its largest new stake was Loar Holdings: 40,883 shares worth $3.52M.
By sector, the portfolio is most concentrated in Technology at 7.6% of assets, up from 7.6% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $847K trimmed.
- Thrive Wealth Management's largest Q2 2025 buy was Loar Holdings: 40,883 shares worth $3.52M.
- Thrive Wealth Management added most to State Street SPDR S&P MIDCAP 400 ETF Trust in Q2 2025, an estimated $11M increase.
- Thrive Wealth Management's biggest Q2 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $847K.
- Thrive Wealth Management fully exited State Street Technology Select Sector SPDR ETF in Q2 2025, selling an estimated $310K.
- Thrive Wealth Management's ten largest holdings make up 62% of its $619M portfolio in Q2 2025.
- Thrive Wealth Management opened 18 new positions and closed 8 in Q2 2025.
- Thrive Wealth Management's portfolio value rose 18% quarter-over-quarter to $619M.
Based on Thrive Wealth Management's 13F filing for Q2 2025, filed 9 Jul 2025.